BrainStorm Cell Therapeutics
BCLI
#10581
Rank
S$12.09 M
Marketcap
S$1.10
Share price
2.41%
Change (1 day)
-28.34%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -S$14.3 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$14.99 Million, an increase over its 2023 earnings that were of -S$22.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$14.3 Million-4.63%
2024 -S$14.99 Million-32.39%
2023 -S$22.17 Million-29.18%
2022 -S$31.31 Million-0.74%
2021 -S$31.54 Million-23.12%
2020 -S$41.02 Million36.8%
2019 -S$29.99 Million66.71%
2018 -S$17.99 Million181.66%
2017 -S$6.39 Million-0.6%
2016 -S$6.43 Million-41.31%
2015 -S$10.95 Million-8.22%
2014 -S$11.93 Million89.74%
2013 -S$6.29 Million42.27%
2012 -S$4.42 Million-12.45%
2011 -S$5.05 Million63.04%
2010 -S$3.1 Million35.52%
2009 -S$2.29 Million-48.99%
2008 -S$4.48 Million-44.39%
2007 -S$8.06 Million
2005 -S$4.17 Million-91.44%
2004 -S$48.72 Million94007.62%
2003 -S$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
S$2.09 B-15,064.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.63 B-90,428.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-S$1.02 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$1.07 Billion 7,549.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$26.64 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-S$0.33 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA